Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation. [electronic resource] by
- Braud, A C
- Mathoulin Portier, M P
- Bardou, V J
- Bertucci, F
- Gravis, G
- Camerlo, J
- Begue, M
- Houvenaeghel, G
- Maraninchi, D
- Jacquemier, J
- Viens, P
Producer: 20030711
In:
Bone marrow transplantation vol. 29
Availability: No items available.
|
|
9.
|
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3. [electronic resource] by
- Jacquemier, J
- Mathoulin-Portier, M P
- Valtola, R
- Charafe-Jauffret, E
- Geneix, J
- Houvenaeghel, G
- Puig, B
- Bardou, V J
- Hassoun, J
- Viens, P
- Birnbaum, D
Producer: 20000321
In:
International journal of cancer vol. 89
Availability: No items available.
|
|
10.
|
Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy. [electronic resource] by
- Mathoulin-Portier, M P
- Meynard, P
- Charton-Bain, M C
- Escoute, M
- Bardou, V J
- Puig, B
- Viens, P
- Cowen, D
- Houvenaeghel, G
- Hassoun, J
- Jacquemier, J
Producer: 19990624
In:
Anticancer research vol. 19
Availability: No items available.
|
|
11.
|
|